SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-16-163803
Filing Date
2016-12-23
Accepted
2016-12-23 18:02:09
Documents
1
Period of Report
2016-10-18

Document Format Files

Seq Description Document Type Size
1 3/A a3a.html 3/A  
1 3/A a3a.xml 3/A 24185
  Complete submission text file 0001104659-16-163803.txt   25510
Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address
Woiwode Thomas (Reporting) CIK: 0001619294 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-37923 | Film No.: 162069509

Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)